Startup Companies
Active startups include companies in which WARF currently holds equity. Successful exits include companies in which WARF invested, which were then either acquired by major corporations or went public.
Interested in learning more about one of these companies? Contact [email protected]
ACTIVE STARTUPS
AIQ Solutions Inc.
Artificial intelligence to evaluate treatment response in complex diseases
Alithic
Carbon capture and mineralization for restorative infrastructure.
C-Motive Technologies
The world's lightest, most powerful non-rare earth electric motors and non-contact power transfer devices
Co-D Therapeutics Inc.
Innovative cancer drug development
Elephas
Developing an imaging platform technology to assess how live tumor cells respond to cancer therapies
Elucent Medical
Innovative surgical navigation tool for tumor excision
FluGen Inc.
Influenza vaccines
Galilei BioSciences Inc.
Developing sirtuin drugs
Imbed Biosciences
Multifunctional polymeric nanofilms technology that provides cutting edge solutions in wound healing
Immuto Scientific
Contract research organization providing analytical research services for drug discovery
Infleqtion
Building an ecosystem of quantum technologies & commercial products, driving the industry towards tomorrow
Innervace
Regenerative therapy company developing technology that acts as pre-formed, anatomically-inspired, implantable tissue pathways to directly replace lost connections due to brain degeneration or injury
Isomark
Non-invasive patented platform technology used to monitor health status by measuring and analyzing isotopic biomarkers through exhaled breath
Leo Cancer Care/Asto CT
Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes through upright positioning
Lynx Biosciences
Personalized cancer treatments to patients
OnLume
Medical device for precise fluorescence image-guided surgery
PROMISS Diagnostics Inc.
Globally accessible, non-invasive and precise diagnostic test for ovarian cancer
Pyran
Produces a renewable, sustainable and cost-effective alternative to an oil-based chemical (1,5-pentanediol) found in everyday materials including paint, nylon and other plastics
Quiver Quantitative
Gathers alternative stock data from across the internet and aggregates it in an easy-to-use web dashboard and mobile app designed for non-professional investors.
SHINE
Creating commercially viable fusion, including vertically integrating neutron and medical isotope production.
Stemina Biomarker Discovery
Metabolomic technologies to understand cell biology in both health and disease
Stuart Therapeutics
First in class ophthalmology drug platform targeting the body’s extracellular matrix.
Transfur
Harmonizes the veterinary referral management process, making it easy to request, send, and review veterinary medical records.
Ubicept
Ubicept revolutionizes how machines perceive the world by combining next-generation image sensors with advanced computer vision algorithms.
Voximetry
Personalized radiopharmaceutical therapy (RPT) that provides increased tumor response, higher quality of life, and longer overall survival for cancer patients.
WIN Therapeutics
Seeking to discover and develop a bispecific antibody therapuetic for the treatment of neuroblastoma
SUCCESSFUL EXITS
AlfaLight
Reliable, rugged and efficient laser and electro-optical systems for defense and security applications
Cellular Dynamics International
Fully functioning human cells in industrial quantities IPO preceded acquisition Acquired by Fujifilm in 2015
Gala Design Inc.
Pharmaceuticals and biotech company focused on pharmaceutical preparations business
NeuWave Medical
Fast, minimally invasive and highly effective soft tissue ablation system Acquired by Ethicon in 2016
NimbleGen Inc.
DNA microarrays, consumables and instruments Acquired by Roche in 2007
Silatronix Inc.
Organosilicon compounds for energy storage devices, especially electrolytes for lithium-ion batteries
Stratatech Corporation
Skin regeneration and repair products for therapeutic use Acquired by Mallinckrodt Pharmaceuticals in 2016
StudyBlue
Online studying platform for high school and college students
Third Wave Technologies
Molecular diagnostics for DNA and RNA analysis applications Acquired by Hologic in 2008
Tissue Regeneration Systems
Skeletal reconstruction and bone regeneration technology
TomoTherapy
Precise cancer treatment system IPO preceded acquisition Acquired by Accuray in 2011
Virent Inc.
Platform that converts soluble biomass-derived sugars into gasoline, diesel and more Acquired by TESORO in 2016